Prevail Innovative Wealth Advisors, LLC Abb Vie Inc. Transaction History
Prevail Innovative Wealth Advisors, LLC
- $375 Billion
- Q1 2025
A detailed history of Prevail Innovative Wealth Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Prevail Innovative Wealth Advisors, LLC holds 4,388 shares of ABBV stock, worth $856,098. This represents 0.24% of its overall portfolio holdings.
Number of Shares
4,388
Previous 1,932
127.12%
Holding current value
$856,098
Previous $343 Million
167.79%
% of portfolio
0.24%
Previous 0.1%
Shares
3 transactions
Others Institutions Holding ABBV
# of Institutions
4,184Shares Held
1.29BCall Options Held
17.1MPut Options Held
15.1M-
Vanguard Group Inc Valley Forge, PA173MShares$33.8 Billion0.55% of portfolio
-
Black Rock Inc. New York, NY136MShares$26.6 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.6MShares$15.5 Billion0.57% of portfolio
-
Jpmorgan Chase & CO New York, NY51.8MShares$10.1 Billion0.75% of portfolio
-
Morgan Stanley New York, NY39.7MShares$7.74 Billion0.51% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $345B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...